Ahead of World Diabetes Day on Saturday, Novo has said it will provide $200 million over the next 10 years to support World ...

Biogen's second-quarter results show that sales of Alzheimer's disease therapy Leqembi are continuing to ramp up, driven by a new formulation that avoids the need for infusion clinic visits.

Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...

UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...

The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...

The FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to the label of their products for a rare eye ...